TrialThe Journal of infectious diseases2023

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.

Kara W Chew et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.